bulbocapnine has been researched along with boldine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldessarini, RJ; Branfman, AR; Neumeyer, JL; Zhang, A; Zhang, Y | 1 |
| Acharya, S; Chan, JD; Day, TA; Marchant, JS | 1 |
| Avci, FG; Sariyar Akbulut, B; Sayar, NA | 1 |
1 review(s) available for bulbocapnine and boldine
| Article | Year |
|---|---|
Advances in development of dopaminergic aporphinoids.
Topics: Animals; Apomorphine; Aporphines; Dopamine Agents; Humans; Structure-Activity Relationship | 2007 |
2 other study(ies) available for bulbocapnine and boldine
| Article | Year |
|---|---|
Pharmacological profiling an abundantly expressed schistosome serotonergic GPCR identifies nuciferine as a potent antagonist.
Topics: Animals; Anthelmintics; Aporphines; Drug Evaluation, Preclinical; Locomotion; Receptors, G-Protein-Coupled; Schistosoma mansoni; Serotonergic Neurons; Serotonin Antagonists | 2016 |
An OMIC approach to elaborate the antibacterial mechanisms of different alkaloids.
Topics: Alkaloids; Anti-Bacterial Agents; Aporphines; Bacillus subtilis; Berberine; Drug Discovery; Drug Resistance, Multiple | 2018 |